Access subsidiary secures $70m OcNOS deal for white-box networking

IP Infusion Inc. (IPI), a US subsidiary of Access, has entered into a three-year contract valued at $70 million with UAE-based Evollabs Tech FZ-LLC. The agreement involves IPI licensing OcNOS for white-box network equipment, alongside providing maintenance, support, and undertaking additional feature development based on a three-year roadmap. This move capitalizes on the growing demand for network equipment across data centers, driven by increased investment in AI.

Evollabs Tech FZ-LLC aims to sell network OS combined with hardware primarily to customers in the Middle East. The partnership leverages OcNOS's advantages to offer significant reductions in infrastructure investment and operational costs for network operators. As of December 23, 2025, IPI has confirmed an initial payment of $10 million, part of the $30 million expected by the end of 2025.

Access stated that this transaction is already factored into its full-year consolidated earnings forecast for the fiscal year ending January 2026, which was previously announced on June 30, 2025. The company is cautiously evaluating the accounting treatment of the transaction, noting that the outcome could impact its current consolidated financial performance.